Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year cancer-specific survival at 92% after focal therapy and 99% after prostate removal surgery. Given sparse cancer-specific deaths and a small 10-year follow-up tail, the comparison was statistically inconclusive rather than confirming similar survival. Prostate removal surgery carried much higher odds of perioperative complications, although complication reporting came from different registries and eras.
This article was originally published on MedicalXpress.com
